Osphena® Sales In the first half of the 2013 fiscal year, Osphena® generated 0.1 B yen in revenue, which is probably roughly equivalent to $974,944 U.S. dollars.[12] When Osphena® was put onto the market, it was predicted to earn $495 million in 2017.[13]
This is the worst bunch of losers ever seen in a pharma company! No vision, no motivation, no leadership. Hardly hear from our RD. One guess! I am leaving soon. On my hopefully final interview - out of this industry.
Hear from RD? You must be drunk. They don't care. They deal w DMs only who kiss their asses bc they think too highly of themselves. This place is a dump. If you are a rep and aren't looking then you are really stupid.
